FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk ResearchJessica KeanOctober 10, 2023neuroblastoma, FDA, ODAC, DFMO, relapse, remission
Guest Post: The Transition to Adulthood Begins at Diagnosis SurvivorshipGuest AuthorOctober 3, 2023transitions, executive functions, survivorship
Childhood Cancer Awareness Month Culminates with Big Week of Events in Washington, DC AwarenessJessica KeanSeptember 26, 2023CCAM, Awareness Month, September
Join the National Day of Action for NIH AdvocacyJessica KeanSeptember 14, 2023action day, take action, nih, cancer research
Meet Francesca and Isaac, Survivors Making a Community Impact AdvocacyJessica KeanAugust 10, 2023scholarship, College Scholars Program, cancer survivors, donate blood, Red Cross, bone marrow registry, Be The Match